 | | DKW | | 表記: | (2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)-~{N}-prop-2-ynyl-oxolane-2-carboxamide | | 組成式: | C13 H14 N6 O4 | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH]([CH](O)[CH]3O)C(=O)NCC#C | | InChi: | InChI=1S/C13H14N6O4/c1-2-3-15-12(22)9-7(20)8(21)13(23-9)19-5-18-6-10(14)16-4-17-11(6)19/h1,4-5,7-9,13,20-21H,3H2,(H,15,22)(H2,14,16,17)/t7-,8+,9-,13+/m0/s1 | | 別名: | 6-CARBOXYMETHYLURACIL | | 定義日: | 2018-01-23 | | 最終更新日: | 2021-03-01 | | 公開日: | 2019-02-06 | | 識別子（ID）: | (2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)-~{N}-prop-2-ynyl-oxolane-2-carboxamide |
|
 | | DL5 | | 表記: | Spiro(2,4,6-trinitrobenzene[1,2a]-O2',O3'-methylene-adenosine (beta,gamma-methylene)triphosphate | | 組成式: | C17 H19 N8 O18 P3 | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[P](O)(=O)C[P](O)(O)=O)[CH]4O[C]5(O[CH]34)C(=C[C](C=C5[N+]([O-])=O)=[N+](O)[O-])[N+]([O-])=O | | InChi: | InChI=1S/C17H19N8O18P3/c18-14-11-15(20-4-19-14)22(5-21-11)16-13-12(8(40-16)3-39-46(37,38)43-45(35,36)6-44(32,33)34)41-17(42-13)9(24(28)29)1-7(23(26)27)2-10(17)25(30)31/h1-2,4-5,8,12-13,16H,3,6H2,(H,26,27)(H,35,36)(H,37,38)(H2,18,19,20)(H2,32,33,34)/t8-,12-,13-,16-/m1/s1 | | 別名: | TNP-AMPPCP | | 定義日: | 2015-06-03 | | 最終更新日: | 2021-03-01 | | 公開日: | 2016-04-13 | | 識別子（ID）: | (3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-3',5'-dinitro-N-oxidanyl-6-[[oxidanyl-[oxidanyl(phosphonomethyl)phosphoryl]oxy-phosphoryl]oxymethyl]spiro[3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole-2,4'-cyclohexa-2,5-diene]-1'-imine oxide |
|
 | | DLM | | 表記: | 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium | | 組成式: | C15 H11 O7 | | SMILES: | Oc1cc(cc(O)c1O)c3[o+]c2cc(O)cc(O)c2cc3O | | InChi: | InChI=1S/C15H10O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-5H,(H5-,16,17,18,19,20,21)/p+1 | | 別名: | Delphinidin | | 定義日: | 2014-10-15 | | 最終更新日: | 2021-03-01 | | 公開日: | 2015-01-21 | | 識別子（ID）: | 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium |
|
 | | DLP | | 表記: | 1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | | 組成式: | C44 H80 N O8 P | | SMILES: | O=C(OCC(OC(=O)CCCCCCCC=C/CC=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C)CCCCCCCC=C/CC=C/CCCCC | | InChi: | InChI=1S/C44H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14-17,20-23,42H,6-13,18-19,24-41H2,1-5H3/b16-14-,17-15-,22-20-,23-21-/t42-/m1/s1 | | 別名: | DI-LINOLEOYL-3-SN-PHOSPHATIDYLCHOLINE | | 定義日: | 2002-05-13 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate |
|
 | | DLU | | 表記: | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | | 組成式: | C20 H19 F2 N3 O5 | | SMILES: | Fc1ccc(c(F)c1)CNC(=O)C4=CN3C(C(=O)N2C(CCOC2C3)C)=C(O)C4=O | | InChi: | InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1 | | 別名: | Dolutegravir | | 定義日: | 2011-05-23 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
 | | 07L | | 表記: | 7-hydroxy-2H-chromen-2-one | | 組成式: | C9 H6 O3 | | SMILES: | O=C2Oc1cc(O)ccc1C=C2 | | InChi: | InChI=1S/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H | | 別名: | 7-hydroxycoumarin | | 定義日: | 2011-09-29 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 7-hydroxy-2H-chromen-2-one |
|
 | | DM2 | | 表記: | DOXORUBICIN | | 組成式: | C27 H29 N O11 | | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)CO)CC5OC4OC(C(O)C(N)C4)C | | InChi: | InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 | | 別名: | ADRIAMYCIN | | 定義日: | 1999-07-08 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
|
 | | DM6 | | 表記: | 4'-EPIDOXORUBICIN | | 組成式: | C27 H30 N O11 | | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)CO)CC5OC4OC(C(O)C(C4)[NH3+])C | | InChi: | InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/p+1/t10-,13-,15-,17-,22-,27-/m0/s1 | | 別名: | 4'-EPIADRIAMYCIN | | 定義日: | 1999-07-08 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-ammonio-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside |
|
 | | DMC | | 表記: | 3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID | | 組成式: | C14 H19 N O3 | | SMILES: | O=C(O)/C(=C/c1ccc(cc1O)N(CC)CC)C | | InChi: | InChI=1S/C14H19NO3/c1-4-15(5-2)12-7-6-11(13(16)9-12)8-10(3)14(17)18/h6-9,16H,4-5H2,1-3H3,(H,17,18)/b10-8+ | | 別名: | PARA-DIETHYLAMINO-O-HYDROXY-ALPHA-METHYL CINNAMIC ACID | | 定義日: | 1999-07-08 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (2E)-3-[4-(diethylamino)-2-hydroxyphenyl]-2-methylprop-2-enoic acid |
|
 | | DMQ | | 表記: | [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS([(3-AMINO)PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPINONE | | 組成式: | C33 H36 N4 O3 | | SMILES: | O=C1N(C(C(O)C(O)C(N1Cc2cccc(N)c2)Cc3ccccc3)Cc4ccccc4)Cc5cccc(N)c5 | | InChi: | InChI=1S/C33H36N4O3/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26/h1-18,29-32,38-39H,19-22,34-35H2/t29-,30-,31+,32+/m1/s1 | | 別名: | DMP450(INHIBITOR OF DUPONT MERCK) | | 定義日: | 1999-07-08 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (4R,5S,6S,7R)-1,3-bis(3-aminobenzyl)-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one |
|
 | | DMU | | 表記: | DECYL-BETA-D-MALTOPYRANOSIDE | | 組成式: | C22 H42 O11 | | SMILES: | O(CCCCCCCCCC)C2OC(C(OC1OC(CO)C(O)C(O)C1O)C(O)C2O)CO | | InChi: | InChI=1S/C22H42O11/c1-2-3-4-5-6-7-8-9-10-30-21-19(29)17(27)20(14(12-24)32-21)33-22-18(28)16(26)15(25)13(11-23)31-22/h13-29H,2-12H2,1H3/t13-,14-,15-,16+,17-,18-,19-,20-,21-,22-/m1/s1 | | 別名: | DECYLMALTOSIDE | | 定義日: | 2003-12-02 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | decyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside |
|
 | | DMZ | | 表記: | 4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE | | 組成式: | C17 H17 N3 O2 S | | SMILES: | O=S(=O)(c1ccc(cc1)C)N(c3ccnn3c2ccccc2)C | | InChi: | InChI=1S/C17H17N3O2S/c1-14-8-10-16(11-9-14)23(21,22)19(2)17-12-13-18-20(17)15-6-4-3-5-7-15/h3-13H,1-2H3 | | 別名: | DIMETHYLSULFAPHENAZOLE | | 定義日: | 2002-11-22 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | N,4-dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide |
|
 | | 08P | | 表記: | N-(carboxycarbonyl)-D-cysteine | | 組成式: | C5 H7 N O5 S | | SMILES: | O=C(C(=O)O)NC(C(=O)O)CS | | InChi: | InChI=1S/C5H7NO5S/c7-3(5(10)11)6-2(1-12)4(8)9/h2,12H,1H2,(H,6,7)(H,8,9)(H,10,11)/t2-/m1/s1 | | 別名: | N-oxalyl-D-cysteine | | 定義日: | 2011-10-17 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | N-(carboxycarbonyl)-D-cysteine |
|
 | | DN2 | | 表記: | 3-({(2S)-2-[({(1S)-1-[({(1S)-1-[(R)-CARBOXY(HYDROXY)METHYL]-3,3-DIFLUOROPROPYL}AMINO)CARBONYL]-3-METHYLBUTYL}AMINO)CARBONYL]-2,3-DIHYDRO-1H-INDOL-2-YL}METHYL)THIOPHENE-2-CARBOXYLIC ACID | | 組成式: | C26 H31 F2 N3 O7 S | | SMILES: | O=C(O)C(O)C(NC(=O)C(NC(=O)C2(Nc1ccccc1C2)Cc3c(scc3)C(=O)O)CC(C)C)CC(F)F | | InChi: | InChI=1S/C26H31F2N3O7S/c1-13(2)9-18(22(33)29-17(10-19(27)28)20(32)23(34)35)30-25(38)26(11-14-5-3-4-6-16(14)31-26)12-15-7-8-39-21(15)24(36)37/h3-8,13,17-20,31-32H,9-12H2,1-2H3,(H,29,33)(H,30,38)(H,34,35)(H,36,37)/t17-,18-,20+,26-/m0/s1 | | 別名: | PEPTIDOMIMETIC INHIBITOR | | 定義日: | 2004-07-14 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 3-{[N-({(2S)-2-[(2-carboxythiophen-3-yl)methyl]-2,3-dihydro-1H-indol-2-yl}carbonyl)-L-leucyl]amino}-3,4,5-trideoxy-5,5-difluoro-L-threo-pentonic acid |
|
 | | 08Y | | 表記: | bromoergocryptine | | 組成式: | C32 H40 Br N5 O5 | | SMILES: | Brc7nc6cccc5C4=CC(C(=O)NC1(OC3(O)N(C1=O)C(C(=O)N2CCCC23)CC(C)C)C(C)C)CN(C)C4Cc7c56 | | InChi: | InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1 | | 別名: | bromocriptine | | 定義日: | 2011-10-31 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (5alpha,5'beta)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman |
|
 | | DNB | | 表記: | (2S,3S,4R,5R)-2-(3,4-diaminophenyl)-5-(hydroxymethyl)pyrrolidine-3,4-diol | | 組成式: | C11 H17 N3 O3 | | SMILES: | OC2C(c1ccc(N)c(N)c1)NC(CO)C2O | | InChi: | InChI=1S/C11H17N3O3/c12-6-2-1-5(3-7(6)13)9-11(17)10(16)8(4-15)14-9/h1-3,8-11,14-17H,4,12-13H2/t8-,9+,10-,11+/m1/s1 | | 別名: | Diaminophenyl iminoribitol | | 定義日: | 2009-02-12 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (2S,3S,4R,5R)-2-(3,4-diaminophenyl)-5-(hydroxymethyl)pyrrolidine-3,4-diol |
|
 | | 097 | | 表記: | (2S,3R)-N~4~-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N~1~,2-dihydroxy-3-(2-methylpropyl)butanediamide | | 組成式: | C15 H29 N3 O5 | | SMILES: | CNC(=O)[CH](NC(=O)[CH](CC(C)C)[CH](O)C(=O)NO)C(C)(C)C | | InChi: | InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1 | | 別名: | MARIMASTAT | | 定義日: | 2003-10-16 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxo-butan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide |
|
 | | DNQ | | 表記: | 6,7-DINITROQUINOXALINE-2,3-DIONE | | 組成式: | C8 H2 N4 O6 | | SMILES: | [O-][N+](=O)C=2C(=CC1=NC(=O)C(=O)N=C1C=2)[N+]([O-])=O | | InChi: | InChI=1S/C8H2N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H | | 別名: | DNQX | | 定義日: | 2000-09-27 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 6,7-dinitroquinoxaline-2,3-dione |
|
 | | 09L | | 表記: | 4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one | | 組成式: | C24 H23 F N4 O3 | | SMILES: | O=C(N4CCN(C(=O)c1c(F)ccc(c1)CC3=NNC(=O)c2c3cccc2)CC4)C5CC5 | | InChi: | InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) | | 別名: | Olaparib | | 定義日: | 2011-11-03 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one |
|
 | | 09N | | 表記: | (11Z,14Z)-N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]icosa-11,14-dienamide | | 組成式: | C44 H83 N O9 | | SMILES: | O=C(NC(COC1OC(C(O)C(O)C1O)CO)C(O)C(O)CCCCCCCCCCCCCC)CCCCCCCCCC=C/CC=C/CCCCC | | InChi: | InChI=1S/C44H83NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-23-25-27-29-31-33-39(48)45-36(35-53-44-43(52)42(51)41(50)38(34-46)54-44)40(49)37(47)32-30-28-26-24-22-16-14-12-10-8-6-4-2/h11,13,17-18,36-38,40-44,46-47,49-52H,3-10,12,14-16,19-35H2,1-2H3,(H,45,48)/b13-11-,18-17-/t36-,37+,38+,40-,41-,42-,43+,44-/m0/s1 | | 別名: | C20:2-alpha-galactosylceramide | | 定義日: | 2011-11-04 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (11Z,14Z)-N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]icosa-11,14-dienamide |
|
 | | DOI | | 表記: | 9-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-6-(PHOSPHONOOXY)-9H-PURINE | | 組成式: | C10 H14 N4 O10 P2 | | SMILES: | O=P(O)(O)Oc3ncnc1c3ncn1C2OC(C(O)C2)COP(=O)(O)O | | InChi: | InChI=1S/C10H14N4O10P2/c15-5-1-7(23-6(5)2-22-25(16,17)18)14-4-13-8-9(14)11-3-12-10(8)24-26(19,20)21/h3-7,15H,1-2H2,(H2,16,17,18)(H2,19,20,21)/t5-,6+,7+/m0/s1 | | 別名: | 2'-DEOXY-IMP | | 定義日: | 2006-03-16 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | 9-(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-6-(phosphonooxy)-9H-purine |
|
 | | DOL | | 表記: | 5-(2-DIETHYLAMINO-ETHANESULFONYL)-21-HYDROXY-10-ISOPROPYL-11,19-DIMETHYL-9,26-DIOXA-3,15,28-TRIAZA-TRICYCLO[23.2.1.00,255]OCTACOSA-1(27),12,17,19,25(28)-PENTAENE-2,8,14,23-TETRAONE | | 組成式: | C34 H50 N4 O9 S | | SMILES: | O=S(=O)(CCN(CC)CC)C3CCN2C(=O)c1nc(oc1)CC(=O)CC(O)C=C(C=CCNC(=O)C=CC(C)C(OC(=O)C23)C(C)C)C | | InChi: | InChI=1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9+,12-11+,23-18+/t24-,25-,28-,31-,32-/m1/s1 | | 別名: | DALFOPRISTIN | | 定義日: | 2002-09-26 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (3R,4R,5E,10E,12E,14S,26R,26aS)-26-{[2-(diethylamino)ethyl]sulfonyl}-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25,26,26a-octahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone |
|
 | | DOR | | 表記: | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID | | 組成式: | C5 H6 N2 O4 | | SMILES: | O=C(O)C1NC(=O)NC(=O)C1 | | InChi: | InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)/t2-/m0/s1 | | 別名: | DIHYDROOROTIC ACID | | 定義日: | 2005-02-01 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (4S)-2,6-dioxohexahydropyrimidine-4-carboxylic acid |
|
 | | DOZ | | 表記: | (dimethylamino)(hydroxy)zinc' | | 組成式: | C2 H7 N O Zn | | SMILES: | O[Zn]N(C)C | | InChi: | InChI=1S/C2H6N.H2O.Zn/c1-3-2 | | 別名: | zinc hydroxide dimethylazanide | | 定義日: | 2007-10-03 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | zinc hydroxide dimethylazanide |
|
 | | DP0 | | 表記: | Disopyramide | | 組成式: | C21 H29 N3 O | | SMILES: | O=C(N)C(c1ncccc1)(c2ccccc2)CCN(C(C)C)C(C)C | | InChi: | InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)/t21-/m0/s1 | | 別名: | (2S)-4-(dipropan-2-ylamino)-2-phenyl-2-(pyridin-2-yl)butanamide | | 定義日: | 2010-11-09 | | 最終更新日: | 2021-03-01 | | 識別子（ID）: | (2S)-4-(dipropan-2-ylamino)-2-phenyl-2-(pyridin-2-yl)butanamide |
|
